TreeWAS – Variant ID: rs35407

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
C44 Other malignant neoplasms of skin	1.000	0.000
C43-C44 Melanoma and other malignant neoplasms of skin	1.000	0.000
C43 Malignant melanoma of skin	0.998	0.002
Chapter II Neoplasms	0.992	0.008
# Top node	0.992	0.008
Chapter XII Diseases of the skin and subcutaneous tissue	0.992	0.008
L80-L99 Other disorders of the skin and subcutaneous tissue	0.989	0.011
C44.5 Skin of trunk	0.989	0.011
Chapter V Mental and behavioural disorders	0.982	0.018
Chapter IV Endocrine, nutritional and metabolic diseases	0.982	0.018
C44.3 Skin of other and unspecified parts of face	0.981	0.019
C44.1 Skin of eyelid, including canthus	0.971	0.029
L98 Other disorders of skin and subcutaneous tissue, not elsewhere classified	0.968	0.032
C43.5 Malignant melanoma of trunk	0.962	0.038
L98.9 Disorder of skin and subcutaneous tissue, unspecified	0.959	0.041
F00-F09 Organic, including symptomatic, mental disorders	0.957	0.043
C44.6 Skin of upper limb, including shoulder	0.948	0.052
E70-E90 Metabolic disorders	0.942	0.058
E10-E14 Diabetes mellitus	0.942	0.058
C44.2 Skin of ear and external auricular canal	0.940	0.060
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.938	0.062
C44.4 Skin of scalp and neck	0.936	0.064
C43.7 Malignant melanoma of lower limb, including hip	0.928	0.072
D00-D09 In situ neoplasms	0.921	0.079
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.916	0.084
C43.6 Malignant melanoma of upper limb, including shoulder	0.915	0.085
L82 Seborrhoeic keratosis	0.913	0.087
C44.0 Skin of lip	0.910	0.090
C44.7 Skin of lower limb, including hip	0.898	0.102
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.884	0.116
F05 Delirium, not induced by alcohol and other psychoactive substances	0.881	0.119
D50-D53 Nutritional anaemias	0.879	0.121
E10 Insulin-dependent diabetes mellitus	0.875	0.125
L92 Granulomatous disorders of skin and subcutaneous tissue	0.864	0.136
L90 Atrophic disorders of skin	0.863	0.137
C50-C50 Malignant neoplasm of breast	0.858	0.142
L57 Skin changes due to chronic exposure to nonionising radiation	0.858	0.142
L89 Decubitus ulcer	0.851	0.148
D37-D48 Neoplasms of uncertain or unknown behaviour	0.850	0.150
D04 Carcinoma in situ of skin	0.842	0.158
F10 Mental and behavioural disorders due to use of alcohol	0.836	0.164
F03 Unspecified dementia	0.830	0.170
D50 Iron deficiency anaemia	0.819	0.181
C43.9 Malignant melanoma of skin, unspecified	0.819	0.181
L57.0 Actinic keratosis	0.816	0.184
F05.9 Delirium, unspecified	0.811	0.189
C43.4 Malignant melanoma of scalp and neck	0.808	0.192
L85 Other epidermal thickening	0.804	0.196
E14 Unspecified diabetes mellitus	0.802	0.198
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.798	0.202
F40-F48 Neurotic, stress-related and somatoform disorders	0.797	0.203
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.795	0.205
E10.9 Without complications	0.795	0.205
Chapter XXII Codes for special purposes	0.793	0.207
D03 Melanoma in situ	0.791	0.209
E86 Volume depletion	0.784	0.216
L50-L54 Urticaria and erythema	0.784	0.216
L90.5 Scar conditions and fibrosis of skin	0.779	0.221
D50.9 Iron deficiency anaemia, unspecified	0.778	0.222
E65-E68 Obesity and other hyperalimentation	0.777	0.223
Chapter XX External causes of morbidity and mortality	0.773	0.227
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.770	0.230
Chapter VIII Diseases of the ear and mastoid process	0.768	0.232
L10-L14 Bullous disorders	0.768	0.232
L94 Other localised connective tissue disorders	0.768	0.232
L60-L75 Disorders of skin appendages	0.768	0.232
C50 Malignant neoplasm of breast	0.763	0.237
Chapter VI Diseases of the nervous system	0.762	0.238
F10.3 Withdrawal state	0.760	0.240
L92.9 Granulomatous disorder of skin and subcutaneous tissue, unspecified	0.756	0.244
D09 Carcinoma in situ of other and unspecified sites	0.755	0.245
E87 Other disorders of fluid, electrolyte and acid-base balance	0.754	0.246
Chapter XIV Diseases of the genitourinary system	0.753	0.247
E78 Disorders of lipoprotein metabolism and other lipidaemias	0.753	0.247
D07 Carcinoma in situ of other and unspecified genital organs	0.753	0.247
L98.4 Chronic ulcer of skin, not elsewhere classified	0.749	0.251
C44.9 Malignant neoplasm of skin, unspecified	0.749	0.251
D80-D89 Certain disorders involving the immune mechanism	0.748	0.252
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.745	0.255
E80 Disorders of porphyrin and bilirubin metabolism	0.741	0.259
F10.2 Dependence syndrome	0.739	0.261
C43.1 Malignant melanoma of eyelid, including canthus	0.736	0.264
F06 Other mental disorders due to brain damage and dysfunction and to physical disease	0.734	0.266
E83 Disorders of mineral metabolism	0.734	0.266
L95 Vasculitis limited to skin, not elsewhere classified	0.731	0.269
F02 Dementia in other diseases classified elsewhere	0.727	0.273
F10.0 Acute intoxication	0.727	0.273
F80-F89 Disorders of psychological development	0.726	0.274
E11 Non-insulin-dependent diabetes mellitus	0.726	0.274
Chapter I Certain infectious and parasitic diseases	0.726	0.274
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.725	0.275
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.724	0.276
F99-F99 Unspecified mental disorder	0.723	0.276
C40-C41 Malignant neoplasms of bone and articular cartilage	0.723	0.277
L72 Follicular cysts of skin and subcutaneous tissue	0.721	0.279
C43.0 Malignant melanoma of lip	0.721	0.279
L00-L08 Infections of the skin and subcutaneous tissue	0.719	0.281
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction	0.717	0.283
C44.8 Overlapping lesion of skin	0.717	0.283
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.716	0.284
C43.8 Overlapping malignant melanoma of skin	0.716	0.284
F01 Vascular dementia	0.713	0.287
E10.4 With neurological complications	0.709	0.291
F70-F79 Mental retardation	0.709	0.291
L87 Transepidermal elimination disorders	0.709	0.291
L86 Keratoderma in diseases classified elsewhere	0.709	0.291
L98.1 Factitial dermatitis	0.709	0.291
E20-E35 Disorders of other endocrine glands	0.707	0.293
E88 Other metabolic disorders	0.706	0.294
F00 Dementia in Alzheimer's disease	0.706	0.294
L98.2 Febrile neutrophilic dermatosis [Sweet]	0.706	0.294
L88 Pyoderma gangrenosum	0.705	0.295
Chapter XVI Certain conditions originating in the perinatal period	0.704	0.296
E50-E64 Other nutritional deficiencies	0.704	0.296
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.701	0.299
C43.3 Malignant melanoma of other and unspecified parts of face	0.700	0.300
L85.8 Other specified epidermal thickening	0.699	0.301
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.698	0.302
F09 Unspecified organic or symptomatic mental disorder	0.696	0.304
L99 Other disorders of skin and subcutaneous tissue in diseases classified elsewhere	0.695	0.305
D04.3 Skin of other and unspecified parts of face	0.694	0.305
L98.7 Excessive and redundant skin and subcutaneous tissue	0.694	0.306
L98.6 Other infiltrative disorders of skin and subcutaneous tissue	0.694	0.306
L98.3 Eosinophilic cellulitis [Wells]	0.694	0.306
L92.3 Foreign body granuloma of skin and subcutaneous tissue	0.691	0.309
D52 Folate deficiency anaemia	0.689	0.311
C43.2 Malignant melanoma of ear and external auricular canal	0.688	0.311
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.688	0.312
L56 Other acute skin changes due to ultraviolet radiation	0.687	0.312
D45 Polycythaemia vera	0.686	0.313
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances	0.686	0.314
L98.5 Mucinosis of skin	0.686	0.314
E72 Other disorders of amino-acid metabolism	0.686	0.314
D03.3 Melanoma in situ of other and unspecified parts of face	0.686	0.314
D55-D59 Haemolytic anaemias	0.684	0.316
L89.2 Stage III decubitus ulcer	0.683	0.317
E89.0 Postprocedural hypothyroidism	0.680	0.320
E77 Disorders of glycoprotein metabolism	0.680	0.320
L20-L30 Dermatitis and eczema	0.679	0.321
N70-N77 Inflammatory diseases of female pelvic organs	0.678	0.322
D02 Carcinoma in situ of middle ear and respiratory system	0.678	0.322
N00-N08 Glomerular diseases	0.676	0.324
E76 Disorders of glycosaminoglycan metabolism	0.675	0.325
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.675	0.325
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.675	0.325
E12 Malnutrition-related diabetes mellitus	0.675	0.325
F12 Mental and behavioural disorders due to use of cannabinoids	0.674	0.326
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.673	0.327
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances	0.673	0.327
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.672	0.328
D46 Myelodysplastic syndromes	0.672	0.328
E84 Cystic fibrosis	0.670	0.329
L89.9 Decubitus ulcer and pressure area, unspecified	0.670	0.330
D51 Vitamin B12 deficiency anaemia	0.670	0.330
E13 Other specified diabetes mellitus	0.669	0.330
E79 Disorders of purine and pyrimidine metabolism	0.669	0.331
C51-C58 Malignant neoplasms of female genital organs	0.668	0.332
F05.8 Other delirium	0.667	0.333
E10.2 With renal complications	0.666	0.333
L83 Acanthosis nigricans	0.666	0.334
L91 Hypertrophic disorders of skin	0.665	0.335
F11 Mental and behavioural disorders due to use of opioids	0.665	0.335
E78.5 Hyperlipidaemia, unspecified	0.664	0.336
E85 Amyloidosis	0.664	0.336
F05.0 Delirium not superimposed on dementia, so described	0.663	0.337
D60-D64 Aplastic and other anaemias	0.663	0.337
E70 Disorders of aromatic amino-acid metabolism	0.662	0.338
L58 Radiodermatitis	0.662	0.338
N17-N19 Renal failure	0.662	0.338
D04.5 Skin of trunk	0.662	0.338
F45 Somatoform disorders	0.662	0.338
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.661	0.339
L97 Ulcer of lower limb, not elsewhere classified	0.659	0.341
D04.6 Skin of upper limb, including shoulder	0.658	0.341
L89.1 Stage II decubitus ulcer	0.657	0.342
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.656	0.344
E73 Lactose intolerance	0.656	0.344
F13 Mental and behavioural disorders due to use of sedatives or hypnotics	0.655	0.344
D04.7 Skin of lower limb, including hip	0.655	0.345
L59 Other disorders of skin and subcutaneous tissue related to radiation	0.654	0.345
L98.0 Pyogenic granuloma	0.653	0.347
L80 Vitiligo	0.652	0.347
C50.8 Overlapping lesion of breast	0.653	0.347
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.652	0.348
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.652	0.348
W00-W19 Falls	0.650	0.350
C50.9 Breast, unspecified	0.649	0.351
D01 Carcinoma in situ of other and unspecified digestive organs	0.645	0.355
N72 Inflammatory disease of cervix uteri	0.645	0.355
E14.3 With ophthalmic complications	0.643	0.357
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.643	0.357
L55 Sunburn	0.642	0.358
F60-F69 Disorders of adult personality and behaviour	0.641	0.358
L93 Lupus erythematosus	0.640	0.360
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.639	0.361
C73 Malignant neoplasm of thyroid gland	0.639	0.361
E74 Other disorders of carbohydrate metabolism	0.638	0.362
E10.3 With ophthalmic complications	0.638	0.362
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.637	0.363
E10.7 With multiple complications	0.637	0.363
E10.5 With peripheral circulatory complications	0.637	0.363
E10.8 With unspecified complications	0.636	0.363
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.635	0.364
F18 Mental and behavioural disorders due to use of volatile solvents	0.634	0.366
F16 Mental and behavioural disorders due to use of hallucinogens	0.634	0.366
D07.5 Prostate	0.634	0.366
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine	0.634	0.366
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.633	0.367
D70-D77 Other diseases of blood and blood-forming organs	0.632	0.368
E10.1 With ketoacidosis	0.632	0.368
E10.6 With other specified complications	0.631	0.368
E87.2 Acidosis	0.631	0.369
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified	0.630	0.370
L90.8 Other atrophic disorders of skin	0.629	0.371
L92.2 Granuloma faciale [eosinophilic granuloma of skin]	0.629	0.371
L72.1 Trichilemmal cyst	0.629	0.371
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.628	0.372
F05.1 Delirium superimposed on dementia	0.628	0.372
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.627	0.373
N60-N64 Disorders of breast	0.626	0.374
F20 Schizophrenia	0.626	0.374
L90.9 Atrophic disorder of skin, unspecified	0.625	0.375
G30-G32 Other degenerative diseases of the nervous system	0.624	0.376
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.623	0.377
L57.4 Cutis laxa senilis	0.623	0.377
N03 Chronic nephritic syndrome	0.623	0.377
L89.3 Stage IV decubitus ulcer	0.622	0.377
D04.1 Skin of eyelid, including canthus	0.621	0.379
D04.9 Skin, unspecified	0.621	0.379
H90-H95 Other disorders of ear	0.621	0.379
D09.0 Bladder	0.620	0.380
L92.1 Necrobiosis lipoidica, not elsewhere classified	0.619	0.380
E14.9 Without complications	0.619	0.381
L90.6 Striae atrophicae	0.618	0.381
L90.4 Acrodermatitis chronica atrophicans	0.618	0.381
L90.3 Atrophoderma of Pasini and Pierini	0.618	0.381
L90.2 Anetoderma of Jadassohn-Pellizzari	0.618	0.381
L90.1 Anetoderma of Schweninger-Buzzi	0.618	0.381
F43 Reaction to severe stress, and adjustment disorders	0.618	0.382
L50 Urticaria	0.617	0.383
L57.3 Poikiloderma of Civatte	0.615	0.385
L57.2 Cutis rhomboidalis nuchae	0.615	0.385
L57.1 Actinic reticuloid	0.615	0.385
E66 Obesity	0.615	0.385
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.614	0.385
C50.3 Lower-inner quadrant of breast	0.614	0.386
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.614	0.386
E89.3 Postprocedural hypopituitarism	0.614	0.386
F10.4 Withdrawal state with delirium	0.614	0.386
L92.8 Other granulomatous disorders of skin and subcutaneous tissue	0.613	0.387
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.612	0.388
E87.5 Hyperkalaemia	0.612	0.388
E40-E46 Malnutrition	0.611	0.389
L53 Other erythematous conditions	0.611	0.389
E00-E07 Disorders of thyroid gland	0.611	0.389
D04.2 Skin of ear and external auricular canal	0.610	0.390
L57.8 Other skin changes due to chronic exposure to nonionising radiation	0.610	0.390
D53 Other nutritional anaemias	0.610	0.390
D04.0 Skin of lip	0.609	0.391
E78.9 Disorder of lipoprotein metabolism, unspecified	0.609	0.391
F14 Mental and behavioural disorders due to use of cocaine	0.609	0.391
Y43 Primarily systemic agents	0.608	0.392
Chapter XIII Diseases of the musculoskeletal system and connective tissue	0.607	0.393
L89.0 Stage I decubitus ulcer and pressure area	0.607	0.393
F10.8 Other mental and behavioural disorders	0.605	0.394
L03 Cellulitis	0.605	0.395
D04.8 Skin of other sites	0.604	0.396
D03.4 Melanoma in situ of scalp and neck	0.603	0.397
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.602	0.397
E78.2 Mixed hyperlipidaemia	0.602	0.397
L72.0 Epidermal cyst	0.603	0.397
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system	0.601	0.399
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.600	0.400
F30-F39 Mood [affective] disorders	0.600	0.400
D03.7 Melanoma in situ of lower limb, including hip	0.599	0.400
F10.6 Amnesic syndrome	0.598	0.402
C15-C26 Malignant neoplasms of digestive organs	0.598	0.402
L57.5 Actinic granuloma	0.597	0.403
Y44 Agents primarily affecting blood constituents	0.597	0.403
D04.4 Skin of scalp and neck	0.597	0.403
H80-H83 Diseases of inner ear	0.596	0.404
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.595	0.405
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.595	0.405
C75 Malignant neoplasm of other endocrine glands and related structures	0.595	0.405
D50.1 Sideropenic dysphagia	0.595	0.405
E14.4 With neurological complications	0.594	0.406
E14.8 With unspecified complications	0.593	0.407
D50.0 Iron deficiency anaemia secondary to blood loss (chronic)	0.592	0.408
F42 Obsessive-compulsive disorder	0.591	0.409
D03.5 Melanoma in situ of trunk	0.591	0.409
E14.1 With ketoacidosis	0.591	0.409
E14.5 With peripheral circulatory complications	0.589	0.411
E89.4 Postprocedural ovarian failure	0.588	0.412
C50.5 Lower-outer quadrant of breast	0.588	0.412
C50.1 Central portion of breast	0.587	0.412
D03.2 Melanoma in situ of ear and external auricular canal	0.587	0.413
B15-B19 Viral hepatitis	0.586	0.414
A80-A89 Viral infections of the central nervous system	0.586	0.414
E83.3 Disorders of phosphorus metabolism	0.585	0.415
L94.2 Calcinosis cutis	0.585	0.415
L12 Pemphigoid	0.583	0.417
N18 Chronic renal failure	0.582	0.418
Y57 Other and unspecified drugs and medicaments	0.582	0.418
E89.1 Postprocedural hypoinsulinaemia	0.580	0.420
E14.0 With coma	0.580	0.420
F44 Dissociative [conversion] disorders	0.580	0.420
L72.9 Follicular cyst of skin and subcutaneous tissue, unspecified	0.579	0.420
N03.9 Unspecified	0.579	0.421
E89.8 Other postprocedural endocrine and metabolic disorders	0.579	0.421
L90.0 Lichen sclerosus et atrophicus	0.578	0.421
E78.8 Other disorders of lipoprotein metabolism	0.578	0.422
E89.5 Postprocedural testicular hypofunction	0.578	0.422
F06.7 Mild cognitive disorder	0.578	0.422
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.578	0.422
E87.6 Hypokalaemia	0.577	0.423
E11.4 With neurological complications	0.577	0.423
E65 Localised adiposity	0.576	0.424
L85.3 Xerosis cutis	0.576	0.424
L85.2 Keratosis punctata (palmaris et plantaris)	0.576	0.424
L85.0 Acquired ichthyosis	0.576	0.424
D03.1 Melanoma in situ of eyelid, including canthus	0.576	0.424
L11 Other acantholytic disorders	0.576	0.424
F81 Specific developmental disorders of scholastic skills	0.575	0.425
L92.0 Granuloma annulare	0.575	0.425
E14.7 With multiple complications	0.575	0.425
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.574	0.425
L13 Other bullous disorders	0.573	0.427
Y41 Other systemic anti-infectives and antiparasitics	0.573	0.427
L85.1 Acquired keratosis [keratoderma] palmaris et plantaris	0.572	0.427
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.572	0.427
D69 Purpura and other haemorrhagic conditions	0.572	0.428
F48 Other neurotic disorders	0.572	0.428
C50.6 Axillary tail of breast	0.572	0.428
L84 Corns and callosities	0.571	0.429
V01-V09 Pedestrian injured in transport accident	0.570	0.430
E11.0 With coma	0.570	0.430
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.570	0.430
Y60-Y69 Misadventures to patients during surgical and medical care	0.569	0.431
L94.9 Localised connective tissue disorder, unspecified	0.569	0.431
X58-X59 Accidental exposure to other and unspecified factors	0.569	0.431
L72.8 Other follicular cysts of skin and subcutaneous tissue	0.568	0.432
G50-G59 Nerve, nerve root and plexus disorders	0.568	0.432
G20-G26 Extrapyramidal and movement disorders	0.567	0.433
D03.9 Melanoma in situ, unspecified	0.567	0.433
X00-X09 Exposure to smoke, fire and flames	0.567	0.433
B35-B49 Mycoses	0.567	0.433
D50.8 Other iron deficiency anaemias	0.567	0.433
F10.9 Unspecified mental and behavioural disorder	0.566	0.434
X10-X19 Contact with heat and hot substances	0.566	0.434
E14.6 With other specified complications	0.566	0.434
C74 Malignant neoplasm of adrenal gland	0.565	0.434
F45.8 Other somatoform disorders	0.565	0.435
X30-X39 Exposure to forces of nature	0.565	0.435
G00-G09 Inflammatory diseases of the central nervous system	0.565	0.435
Y10-Y34 Event of undetermined intent	0.565	0.435
B20-B24 Human immunodeficiency virus [HIV] disease	0.564	0.436
E83.4 Disorders of magnesium metabolism	0.564	0.436
D07.4 Penis	0.564	0.436
E80.4 Gilbert's syndrome	0.564	0.436
E27 Other disorders of adrenal gland	0.564	0.436
D86 Sarcoidosis	0.563	0.437
E14.2 Withrenal complications	0.563	0.437
F23 Acute and transient psychotic disorders	0.563	0.437
L40-L45 Papulosquamous disorders	0.562	0.437
F10.7 Residual and late-onset psychotic disorder	0.562	0.438
L29 Pruritus	0.562	0.438
L54 Erythema in diseases classified elsewhere	0.562	0.438
L94.8 Other specified localised connective tissue disorders	0.562	0.438
L68 Hypertrichosis	0.562	0.438
A50-A64 Infections with a predominantly sexual mode of transmission	0.561	0.439
E11.5 With peripheral circulatory complications	0.561	0.439
V70-V79 Bus occupant injured in transport accident	0.560	0.440
C45 Mesothelioma	0.560	0.440
V95-V97 Air and space transport accidents	0.559	0.441
H93 Other disorders of ear, not elsewhere classified	0.559	0.441
E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified	0.559	0.441
V98-V99 Other and unspecified transport accidents	0.558	0.442
F21 Schizotypal disorder	0.557	0.442
E67 Other hyperalimentation	0.557	0.443
E68 Sequelae of hyperalimentation	0.557	0.443
G80-G83 Cerebral palsy and other paralytic syndromes	0.557	0.443
W75-W84 Other accidental threats to breathing	0.556	0.443
E11.2 With renal complications	0.556	0.444
D09.1 Other and unspecified urinary organs	0.556	0.444
D63 Anaemia in chronic diseases classified elsewhere	0.556	0.444
Y46 Antiepileptics and anti-Parkinsonism drugs	0.555	0.444
E10.0 With coma	0.555	0.445
L94.3 Sclerodactyly	0.555	0.445
M40-M43 Deforming dorsopathies	0.555	0.445
Y35-Y36 Legal intervention and operations of war	0.554	0.446
X85-X99 Assault	0.554	0.446
W65-W74 Accidental drowning and submersion	0.554	0.446
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.554	0.446
D52.9 Folate deficiency anaemia, unspecified	0.553	0.447
E66.9 Obesity, unspecified	0.553	0.447
F28 Other nonorganic psychotic disorders	0.552	0.448
F24 Induced delusional disorder	0.552	0.448
D75 Other diseases of blood and blood-forming organs	0.552	0.448
F22 Persistent delusional disorders	0.552	0.448
V90-V94 Water transport accidents	0.552	0.448
X20-X29 Contact with venomous animals and plants	0.551	0.449
D03.8 Melanoma in situ of other sites	0.551	0.449
L14 Bullous disorders in diseases classified elsewhere	0.551	0.449
Y48 Anaesthetics and therapeutic gases	0.551	0.449
L94.6 Ainhum	0.551	0.449
L94.5 Poikiloderma vasculare atrophicans	0.551	0.449
L94.4 Gottron's papules	0.551	0.449
L94.1 Linear scleroderma	0.551	0.449
L75 Apocrine sweat disorders	0.550	0.449
L74 Eccrine sweat disorders	0.550	0.449
L67 Hair colour and hair shaft abnormalities	0.550	0.449
L64 Androgenic alopecia	0.550	0.449
L62 Nail disorders in diseases classified elsewhere	0.550	0.449
D80 Immunodeficiency with predominantly antibody defects	0.550	0.450
V40-V49 Car occupant injured in transport accident	0.550	0.450
D09.9 Carcinoma in situ, unspecified	0.549	0.450
D83 Common variable immunodeficiency	0.549	0.450
D03.0 Melanoma in situ of lip	0.549	0.451
L52 Erythema nodosum	0.549	0.451
G90-G99 Other disorders of the nervous system	0.549	0.451
E80.6 Other disorders of bilirubin metabolism	0.547	0.453
Y53 Agents primarily affecting the gastro-intestinal system	0.547	0.453
F02.0 Dementia in Pick's disease	0.547	0.453
L94.0 Localised scleroderma [morphea]	0.547	0.453
E78.3 Hyperchylomicronaemia	0.547	0.453
D09.7 Carcinoma in situ of other specified sites	0.547	0.453
H60-H62 Diseases of external ear	0.547	0.453
D06 Carcinoma in situ of cervix uteri	0.546	0.453
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.545	0.454
V10-V19 Pedal cyclist injured in transport accident	0.545	0.455
E80.2 Other porphyria	0.545	0.455
D07.0 Endometrium	0.545	0.455
D07.3 Other and unspecified female genital organs	0.544	0.456
Y58 Bacterial vaccines	0.544	0.456
E29 Testicular dysfunction	0.544	0.456
F25 Schizoaffective disorders	0.543	0.457
L95.9 Vasculitis limited to skin, unspecified	0.543	0.457
L51 Erythema multiforme	0.542	0.457
D07.2 Vagina	0.542	0.457
Q80-Q89 Other congenital malformations	0.542	0.458
E83.1 Disorders of iron metabolism	0.542	0.458
D09.3 Thyroid and other endocrine glands	0.542	0.458
D09.2 Eye	0.542	0.458
L63 Alopecia areata	0.541	0.459
D46.9 Myelodysplastic syndrome, unspecified	0.541	0.459
F06.9 Unspecified mental disorder due to brain damage and dysfunction and to physical disease	0.541	0.459
D61 Other aplastic anaemias	0.541	0.459
E87.4 Mixed disorder of acid-base balance	0.541	0.459
E80.1 Porphyria cutanea tarda	0.541	0.459
E11.8 With unspecified complications	0.541	0.459
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites	0.540	0.460
D07.6 Other and unspecified male genital organs	0.540	0.460
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.539	0.461
E16 Other disorders of pancreatic internal secretion	0.539	0.461
D84 Other immunodeficiencies	0.539	0.461
N64 Other disorders of breast	0.539	0.461
F00.9 Dementia in Alzheimer's disease, unspecified	0.538	0.461
F99 Mental disorder, not otherwise specified	0.538	0.462
Y42.5 Other oestrogens and progestogens	0.538	0.462
E78.1 Pure hyperglyceridaemia	0.538	0.462
V20-V29 Motorcycle rider injured in transport accident	0.538	0.462
L66 Cicatricial alopecia [scarring hair loss]	0.538	0.462
G70-G73 Diseases of myoneural junction and muscle	0.538	0.462
D48.5 Skin	0.538	0.462
L70 Acne	0.537	0.462
F40 Phobic anxiety disorders	0.537	0.463
Y49 Psychotropic drugs, not elsewhere classified	0.537	0.463
E80.7 Disorder of bilirubin metabolism, unspecified	0.536	0.463
N71 Inflammatory disease of uterus, except cervix	0.536	0.464
D81 Combined immunodeficiencies	0.536	0.464
E78.6 Lipoprotein deficiency	0.536	0.464
Y47 Sedatives, hypnotics and antianxiety drugs	0.536	0.464
L05 Pilonidal cyst	0.535	0.464
F06.8 Other specified mental disorders due to brain damage and dysfunction and to physical disease	0.535	0.465
F02.3 Dementia in Parkinson's disease	0.535	0.465
Y42.7 Androgens and anabolic congeners	0.534	0.465
X50-X57 Overexertion, travel and privation	0.534	0.466
F29 Unspecified nonorganic psychosis	0.534	0.466
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.534	0.466
E83.9 Disorder of mineral metabolism, unspecified	0.533	0.467
E11.1 With ketoacidosis	0.533	0.467
F10.1 Harmful use	0.533	0.467
F06.3 Organic mood [affective] disorders	0.532	0.468
L10 Pemphigus	0.532	0.468
D82 Immunodeficiency associated with other major defects	0.532	0.468
E80.5 Crigler-Najjar syndrome	0.531	0.468
E80.3 Defects of catalase and peroxydase	0.531	0.468
E80.0 Hereditary erythropoietic porphyria	0.531	0.468
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency	0.531	0.469
D48.1 Connective and other soft tissue	0.531	0.469
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.531	0.469
F07.2 Postconcussional syndrome	0.531	0.469
E34 Other endocrine disorders	0.530	0.469
F01.9 Vascular dementia, unspecified	0.530	0.470
V80-V89 Other land transport accidents	0.530	0.470
E87.7 Fluid overload	0.529	0.471
D67 Hereditary factor IX deficiency	0.529	0.471
W50-W64 Exposure to animate mechanical forces	0.528	0.472
L95.8 Other vasculitis limited to skin	0.528	0.472
N99-N99 Other disorders of the genitourinary system	0.528	0.472

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations